https://www.theedgeresearch.com/news TheEdgeResearch en 2026-05-31 Revolution's pancreatic cancer drug doubles survival, boosts quality of life 2026-05-31 https://www.theedgeresearch.com/quote/CALX TheEdgeResearch en 2026-05-31 CALX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Calix (CALX) Investors of Securities Class Action Deadline on July 27, 2026 2026-05-31 https://www.theedgeresearch.com/quote/AVAV TheEdgeResearch en 2026-05-31 AVAV DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds AeroVironment (AVAV) Investors of Securities Class Action Deadline on July 27, 2026 2026-05-31 https://www.theedgeresearch.com/quote/ARM TheEdgeResearch en 2026-05-31 Wall Street Week Ahead 2026-05-31 https://www.theedgeresearch.com/quote/BCS TheEdgeResearch en 2026-05-31 ROSEN, LEADING INVESTOR COUNSEL, Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS 2026-05-31 https://www.theedgeresearch.com/quote/RVMD TheEdgeResearch en 2026-05-31 Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer 2026-05-31 https://www.theedgeresearch.com/quote/AKESF TheEdgeResearch en 2026-05-31 Akeso lung cancer drug helps patients live 15% longer than immunotherapy in China trial 2026-05-31 https://www.theedgeresearch.com/quote/JNJ TheEdgeResearch en 2026-05-31 J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study 2026-05-31 https://www.theedgeresearch.com/quote/LLY TheEdgeResearch en 2026-05-31 Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer 2026-05-31 https://www.theedgeresearch.com/quote/EPOL TheEdgeResearch en 2026-05-31 How Poland Became Europe's Growth Leader 2026-05-31